SEIZURES AFTER USE AND ABUSE OF TRAMADOL. University Toxicology Clinic, Skopje, R. Macedonia 2. University Neurology Clinic, Skopje, R.

Size: px
Start display at page:

Download "SEIZURES AFTER USE AND ABUSE OF TRAMADOL. University Toxicology Clinic, Skopje, R. Macedonia 2. University Neurology Clinic, Skopje, R."

Transcription

1 Prilozi, Odd. biol. med. nauki, MANU, XXXIII, 1, s (2012) Contributions, Sec. Biol. Med. Sci., MASA, XXXIII, 1, p (2012) ISSN UDC: : CASE REPORT SEIZURES AFTER USE AND ABUSE OF TRAMADOL Bekjarovski N 1, Chaparoska D 1, Radulovikj-Bekjarovska S 2 1 University Toxicology Clinic, Skopje, R. Macedonia 2 University Neurology Clinic, Skopje, R. Macedonia Abstract: Seizures have been reported with tramadol monotherapy in animal and human studies, both at recommended and high doses. After tramadol abuse or overdose, neurotoxicity is speculated to be related to the reuptake inhibition of serotonin and norepinephrine, rather than its opioid effects. THE AIM OF THIS STUDY is to show three unusual cases of seizures provoked by tramadol. Case reports: A 56 year-old female was hospitalized with intensive lumbosacral pain. Because the standard therapy with non steroid anti-inflammatory drugs and diazepam did not show enough pain release, Tramadol ampoules were applied. Fifteen minutes later generalized tonic clonic seizure wаs noticed. A 24 year-old female was admitted to the Toxicology Clinic, one hour after ingestion of 1000 mg Tramadol (20 pills of 50 mg) in a suicide attempt. Five hours later generalized tonic clonic seizure was noticed. A 27 year-old male was hospitalized for detoxification procedure with buprenorphine. The patient was a more than four years heroin abuser, and in the last two years he mixed the heroin with high doses of tramadol. 16 hours later, after application of the first 2 mg of Buprenorphine, generalized tonic clonic seizure was noticed. Conclusion: Tramadol prescription, use and abuse are connected with the risk of developing seizures. The neurotoxicity of tramadol commonly manifests as seizures. Key words: tramadol, use/abuse, seizures

2 314 Bekjarovski N Introduction "Divinum est opus, sedare dolorem" says an old Latin proverb. Picture no. 1 Billions of dollars are spent every year on analgesics all around the world. In Australia, the cost of managing chronic pain is estimated to be $34 billion per year [1]. Given the narcotic alternatives for treatment, tramadol is a unique pharmacological bullet in the fight against chronic pain. To attest to its popularity, prescriptions for tramadol in Canada reached almost 26 million in 2006, representing total sales of $800 million [2]. Tramadol is an analgesic medication that is a synthetic analogue of codeine. In comparison with other opiates, tramadol is renowned for having less abuse potential and less respiratory depression. In terms of specific neurotransmitter effects, at the central level, tramadol is a mu-opioid receptor agonist. The affinity of tramadol for mu-opioid receptors (analgesic effect) is 10-fold less than codeine. However, the active metabolite of tramadol, o-desmethyltramadol, has a far greater affinity (up to 200-fold) than the parent compound. In addition to its central effects on mu receptors, at the peripheral level, tramadol inhibits serotonin and norepinephrine reuptake. These latter effects are likely to be an important element in analgesia, but may also account for some of the adverse properties of the drug [3]. Tramadol has many characteristics that are similar to venlafaxine, including structural similarities and serotonergic/noradrenergic reuptake inhibition [4]. Not surprisingly, using liquid chromatography to detect levels of tramadol in urine, venlafaxine may cause false positive results [5]. Seizures have been reported with tramadol monotherapy in animal and human studies, both at recommended and high doses [6, 7]. After tramadol abuse or overdose, neurotoxicity is speculated to be related to the reuptake inhibition of serotonin and norepinephrine, rather than its opioid effects. Patients with an existing seizure disorder appear to be most at risk of adverse effects [8]. The aim of this study is to show three unusual cases of seizures provoked by tramadol, treated at the University Toxicology and Neurology Clinics. Contributions, Sec. Biol. Med. Sci., XXXIII/1 (2012),

3 Seizures after use and abuse of tramadol 315 Case report 1 A 56 year-old female was hospitalized at the University Toxicology Clinic in Skopje with intensive lumbosacral pain. CT of lumbosacral vertebrae showed nerve compression on segment L [4, 5]. The standard therapy with non steroid anti-inflammatory drugs and diazepam, applied in the first two days of hospitalization, did not show enough pain release and in the next few days a Tramadol ampoule of 100 mg two times/day was applied. 15 minutes after the fourth ampoule was applied, generalized tonic clonic seizure was noticed. The seizure was successfully treated with 5 mg intravenous Diazepam. The medication was immediately ceased and no further seizures were noticed. Brain computed tomography (CT) and magnetic resonance imaging (MRI) were normal. An electroencephalogram (EEG) showed no epileptiform activity. Case report 2 A 24 year-old female was admitted to the University Toxicology Clinic in Skopje, one hour after ingestion of 1000 mg Tramadol (20 pills of 50 mg) in a suicide attempt. At admittance she was somnolent (Glasgow Coma Score 11), eupnoic, hypotensive (11/7 kpa). After standard detoxification procedure, saline infusions with vitamins were applied. Five hours later generalized tonic clonic seizure was noticed. The seizure was successfully treated with 10mg i.v. diazepam and continued with 2 mg tablets of Lorazepam in the next four days. The patient had no prior history of epilepsy or convulsions. The patient was discharged without any sequels or further seizures 96 hours after admittance. The further neurological examination (EEG, CT) did not show any disturbances. Case report 3 A 27 year-old male was hospitalized to the University Toxicology Clinic in Skopje, for a standard detoxification procedure with buprenorphine. The patient had a history of more than four years as a heroin abuser, and in the last two years he mixed the heroin with high doses of tramadol (approximately mg two to three times weekly). No evidence of prior seizures was noted. 16 hours later, after application of the first 2 mg of Buprenorphine generalized tonic clonic seizure was noticed. The seizure was successfully treated with 10 mg i.v. diazepam, and 5 mg given orally in the next three days. Detoxification was successfully finished in the next six days, without any neurological signs. EEG did not show any abnormalities. Discussion We present three unusual cases of generalized tonic clonic seizures after use and acute/chronic abuse of Tramadol. Prilozi, Odd. biol. med. nauki, XXXIII/1 (2012),

4 316 Bekjarovski N In the first case, the seizures were noticed after two days of treatment with therapeutic doses of Tramadol. According to our data base this is the first registered case of seizures after therapeutic use in the Republic of Macedonia. Few studies have analysed this phenomenon. Gardner et al. examined a cohort of more than 9,000 patients taking tramadol in a managed care population. While fewer than one percent (80) had an alleged seizure after their first prescription of tramadol, the risk increased 2- to 6-fold when adjusted for selected medical comorbidities and concomitant prescribed drugs. In an Australian study, Labate et al. found that 8.2 percent of new-onset seizures were accounted for by tramadol exposure [9, 10]. However, an additional study found no increased risk of seizures with tramadol monotherapy, and another concluded that there was no higher risk compared to other analgesic monotherapies [11, 12]. Seizures after acute poisoning with tramadol, as in our second case, are not so rare in world statistics, but this is the first case in our Clinic from the total number of 17 patients poisoned with Tramadol in the last decade. A lot of studies and case reports describe the same manifestation after acute poisoning with tramadol. Fakhroldin Taghadosi et al. in his study analyzed 400 patients intoxicated with tramadol, and found that more than 30% developed seizures [13]. In another Iranian study the percentage of the seizures after tramadol intoxications was estimated at about 46%. In the same study, the authors found no significant correlation between ingested dose and seizures [14]. The highest percentage of seizures after acute poisoning with tramadol (54,4%) was noticed in the study published in 2006 [15]. Tramadol dependence and withdrawal are not uncommon and have been reported, particularly after abrupt cessation of long-term treatment. Tramadol withdrawal resembles opioid withdrawal, however in some instances atypical neuropsychiatric symptoms including hallucinations, psychomotor agitation and confusion have been reported [16]. Seizures are not common. There is not sufficient evidence and relevant data about this, and all current knowledge is based on case reports. According to our knowledge, the third presented case is the first reported case of seizures of a patient with tramadol withdrawal syndrome, treated with buprenorphine. Conclusion Tramadol prescription is associated with the risk of developing seizures. Tramadol has relatively high potential to provoke seizures after acute overdose. Seizures may be a feature of atypical withdrawal. The neurotoxicity of tramadol commonly manifests as generalized tonic-clonic seizures. Contributions, Sec. Biol. Med. Sci., XXXIII/1 (2012),

5 Seizures after use and abuse of tramadol 317 REFERENCES 1. Randy A. Sansone, Lori A. Sansone, Tramadol Seizures, Serotonin Syndrome, and Coadministered Antidepressants. Psychiatry (Edgmont) April; 6(4): King M. Local pharmas join lucrative battle against pain. The Gazette (Montreal) Jul 13: B2. 3. Gold Standard, Inc. Tramadol. [Accessed on 12/16/08]; Clinical Pharmacology [database online]. 4. Reeves RR, Cox SK. Similar effects of tramadol and venlafaxine in major depressive disorder.south Med J. 2008; 101: Allen KR. Interference by venlafaxine ingestion in the detection of tramadol by liquid chromatography linked to tandem mass spectrometry for the screening of illicit drugs in human urine. Clin Toxicol (Phila). 2006; 44: Ripple MG, Pestaner JP, Levine BS, Smialek JE. Lethal combination of tramadol and multiple drugs affecting serotonin. Am J Forensic Med Pathol. 2000; 21: Daubin C, Quentin C, Goulle JP, et al. Refractory shock and asystole related to tramadol overdose. Clin Toxicol (Phila). 2007; 45: Spiller HA, Gorman SE, Villalobos D, et al. Prospective multicenter evaluation of tramadol exposure. J Toxicol Clin Toxicol. 1997; 35: Gardner JS, Blough D, Drinkard CR, et al. Tramadol and seizures: a surveillance study in a managed care population. Pharmacotherapy. 2000; 20: Labate A, Newton MR, Vernon GM, Berkovic SF. Tramadol and newonset seizures. Med J Aust. 2005; 182: Jick H, Derby LE, Vasilakis C, Fife D. The risk of seizures associated with tramadol.pharmacotherapy. 1998; 18: Gasse C, Derby L, Vasilakis-Scaramozza C, Jick H. Incidence of first-time idiopathic seizures in users of tramadol. Pharmacotherapy. 2000; 20: Fakhroldin Taghadosi-nejad, Ali Seghatoleslami, Omid Mehrpour, Nasrin Chalaki. Seizure due to Tramadol Poisoning; Clin Toxicol (Phila). 2008; 24(2): Talaie H, Panahandeh R, Fayaznouri M, Asadi Z, Abdollahi M. Doseindependent occurrence of seizure with tramadol. J Med Toxicol Jun; 5(2): Jovanović-Cupić V, Martinović Z, Nesić N. Seizures associated with intoxication and abuse of tramadol. Clin Toxicol (Phila). 2006; 44(2): Senay EC, Adams EH, Geller A, et al. Physical dependence of Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur. Drug Alcohol Depend. 2003; 69: Prilozi, Odd. biol. med. nauki, XXXIII/1 (2012),

6 318 Bekjarovski N Резиме КОНВУЛЗИИ ПРИ УПОТРЕБА И ЗЛОУПОТРЕБА НА ТРАМАДОЛ Беќаровски Н. 1, Чапароска Д. 1, Радуловиќ Беќаровска С. 2 1 Универзиtеtска клиника за tоксиколоgија, Скоpје, Р. Македонија 2 Универзиtеtска клиника за невролоgија, Скоpје Р. Македонија Епилептичните напади се евидентирани при употреба на трамадол во студии со експериментални животни и луѓе, како во терапевтски така и во високи токсични дози. По злоупотреба или труење со трамадол, невротоксичноста се претпоставува дека е предизвикана со повратната инхибиција на серотонинот и норепинефринот, а многу помалку од опијатниот ефект. Цел на трудот е да се прикажат три различни случаи на епилептични напади провоцирани од трамадол. Приказ на случаи: 56-годишна жена е хоспитализирана поради лумбосакрална болка. Бидејќи стандардната терапија со нестероидни антиинфламаторни лекови и дијазепам не даде задоволителен терапевтски одговор, беа ординирани ампули трамадол. 15 минути по апликацијата беа нотирани генерализирани тонично-клонични епилептични напади. 24-годишна жена е донесена на Клиниката за токсикологија по ингестија на 1000 mg трамадол (20 таблети по 50 mg) при обид за самоубиство. Пет часа подоцна беа регистрирани генерализирани тонично-клонични грчеви. 27-годишен маж е хоспитализиран за детоксикација со бупренорфин. Пациентот повеќе од четири години е хероински корисник, а последните две години хероинот го комбинира со високи дози на трамадол. 16 часа по внесот на 2 mg бупренорфин регистриран е интензивен генерализиран тонично-клоничен епилептичен напад. Заклучок: Употребата и злоупотребата на трамадол е поврзана со зголемен ризик од појава на епилептиформни напади. Невротоксичноста на трамадолот најчесто се манифестира со епилептични напади. Клучни зборови: трамадол, употреба/злоупотреба, епилептични напади. Corresponding Author: Bekjarovski N University Toxicology Clinic, Skopje, R. Macedonia Contributions, Sec. Biol. Med. Sci., XXXIII/1 (2012),

7 Seizures after use and abuse of tramadol 319 Mob Prilozi, Odd. biol. med. nauki, XXXIII/1 (2012),

Factors Related to Seizure in Tramadol Poisoning and Its Blood Concentration

Factors Related to Seizure in Tramadol Poisoning and Its Blood Concentration Factors Related to Seizure in Tramadol Poisoning and Its Blood Concentration Fakhreddin Taghaddosinejad, Omid Mehrpour, Reza Afshari, Alireza Seghatoleslami, Mohammad Abdollahi & Richard C. Dart Journal

More information

Ultram (tramadol), Ultram ER (tramadol extended-release tablets); Conzip (tramadol extended-release capsules), Ultracet (tramadol / acetaminophen)

Ultram (tramadol), Ultram ER (tramadol extended-release tablets); Conzip (tramadol extended-release capsules), Ultracet (tramadol / acetaminophen) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.02.35 Subject: Tramadol Acetaminophen Page: 1 of 8 Last Review Date: September 18, 2015 Tramadol Acetaminophen

More information

Alcohol Withdrawal Syndrome & CIWA Assessment

Alcohol Withdrawal Syndrome & CIWA Assessment Alcohol Withdrawal Syndrome & CIWA Assessment Alcohol Withdrawal Syndrome is a set of symptoms that can occur when an individual reduces or stops alcoholic consumption after long periods of use. Prolonged

More information

Elements for a public summary. VI.2.1 Overview of disease epidemiology. VI.2.2 Summary of treatment benefits

Elements for a public summary. VI.2.1 Overview of disease epidemiology. VI.2.2 Summary of treatment benefits VI.2 Elements for a public summary VI.2.1 Overview of disease epidemiology Pain is one of the most common reasons for a patient to seek medical attention. Moderate or severe intensity pain can be acute

More information

1. According to recent US national estimates, which of the following substances is associated

1. According to recent US national estimates, which of the following substances is associated 1 Chapter 36. Substance-Related, Self-Assessment Questions 1. According to recent US national estimates, which of the following substances is associated with the highest incidence of new drug initiates

More information

OPIOIDS. Petros Levounis, MD, MA Chair Department of Psychiatry Rutgers New Jersey Medical School

OPIOIDS. Petros Levounis, MD, MA Chair Department of Psychiatry Rutgers New Jersey Medical School OPIOIDS Petros Levounis, MD, MA Chair Department of Psychiatry Rutgers New Jersey Medical School Rutgers New Jersey Medical School Fundamentals of Addiction Medicine Summer Series Newark, NJ July 24, 2013

More information

How To Treat Anorexic Addiction With Medication Assisted Treatment

How To Treat Anorexic Addiction With Medication Assisted Treatment Medication Assisted Treatment for Opioid Addiction Tanya Hiser, MS, LPC Premier Care of Wisconsin, LLC October 21, 2015 How Did We Get Here? Civil War veterans and women 19th Century physicians cautious

More information

Considerations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT

Considerations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT Considerations in Medication Assisted Treatment of Opiate Dependence Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT Disclosures Speaker Panels- None Grant recipient - SAMHSA

More information

Substitution Therapy for Opioid Dependence The Role of Suboxone. Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015

Substitution Therapy for Opioid Dependence The Role of Suboxone. Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015 Substitution Therapy for Opioid Dependence The Role of Suboxone Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015 Objectives Recognize the options available in treating opioid

More information

Prior Authorization Guideline

Prior Authorization Guideline Prior Authorization Guideline Guideline: CSD - Suboxone Therapeutic Class: Central Nervous System Agents Therapeutic Sub-Class: Analgesics and Antipyretics (Opiate Partial Agonists) Client: County of San

More information

13. Substance Misuse

13. Substance Misuse 13. Substance Misuse Definitions Misuse or abuse this is the taking of something with the intention of producing pleasurable mind-altering effects, intoxication or altered body image. The mind-altering

More information

MAT Counselor Education Course Exam Questions Packet Part 1

MAT Counselor Education Course Exam Questions Packet Part 1 MAT Counselor Education Course Exam Questions Packet Part 1 Course No: Course Title: Course Objective: MA-1901P1 Medication-Assisted Treatment (MAT) Counselor Education Course Part 1 Includes primer on

More information

Hospital Management of Opioid Dependence. Dependence. Disclosure. Pharmacologic Management. Methadone Utilization. Hospital Management of Opioid

Hospital Management of Opioid Dependence. Dependence. Disclosure. Pharmacologic Management. Methadone Utilization. Hospital Management of Opioid Disclosure Hospital Management of Opioid Dependence Attended Buprenorphine advisory board meeting (Schering Canada) May 2007, but personal honorarium/compensation was declined Dr. Alex Chan alexchchan@hotmail.com

More information

Table of Contents. I. Introduction... 2. II. Summary... 3. A. Total Drug Intoxication Deaths... 5. B. Opioid-Related Deaths... 9

Table of Contents. I. Introduction... 2. II. Summary... 3. A. Total Drug Intoxication Deaths... 5. B. Opioid-Related Deaths... 9 Table of Contents I. Introduction... 2 II. Summary... 3 III. Charts A. Total Drug Intoxication Deaths... 5 B. Opioid-Related Deaths... 9 C. Heroin-Related Deaths... 11 D. Prescription Opioid-Related Deaths...

More information

Tufts Health Care Institute Program on Opioid Risk Management Pharmacotherapy for Prescription Opioid Addiction: Implications for Pain Management

Tufts Health Care Institute Program on Opioid Risk Management Pharmacotherapy for Prescription Opioid Addiction: Implications for Pain Management Tufts Health Care Institute Program on Opioid Risk Management Pharmacotherapy for Prescription Opioid Addiction: Implications for Pain Management June 10 and 11, 2011 Executive Summary Introduction Opioid

More information

Philip Moore DO, Toxicology Fellow, PinnacleHealth Toxicology Center Joanne Konick-McMahan RN MSRN, Staff RN, PinnacleHealth

Philip Moore DO, Toxicology Fellow, PinnacleHealth Toxicology Center Joanne Konick-McMahan RN MSRN, Staff RN, PinnacleHealth Philip Moore DO, Toxicology Fellow, PinnacleHealth Toxicology Center Joanne Konick-McMahan RN MSRN, Staff RN, PinnacleHealth I. II. Background A. AWS can occur in anyone who consumes alcohol B. Risk correlates

More information

Care Management Council submission date: August 2013. Contact Information

Care Management Council submission date: August 2013. Contact Information Clinical Practice Approval Form Clinical Practice Title: Acute use of Buprenorphine for the Treatment of Opioid Dependence and Detoxification Type of Review: New Clinical Practice Revisions of Existing

More information

Dosing Guide. For Optimal Management of Opioid Dependence

Dosing Guide. For Optimal Management of Opioid Dependence Dosing Guide For Optimal Management of Opioid Dependence KEY POINTS The goal of induction is to safely suppress opioid withdrawal as rapidly as possible with adequate doses of Suboxone (buprenorphine HCl/naloxone

More information

The CCB Science 2 Service Distance Learning Program

The CCB Science 2 Service Distance Learning Program S2S 2055 DETOXIFICATION Module 1 Post-Test 1. A common use of a biochemical marker is. a. to support or refute other information that leads to proper diagnosis b. for forensic purposes c. in detecting

More information

Information for Pharmacists

Information for Pharmacists Page 43 by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose. Information for Pharmacists SUBOXONE (buprenorphine HCl/naloxone HCl

More information

This is the written version of our Hot Topic video presentation available at: MayoMedicalLaboratories.com/hot-topics

This is the written version of our Hot Topic video presentation available at: MayoMedicalLaboratories.com/hot-topics This is the written version of our Hot Topic video presentation available at: MayoMedicalLaboratories.com/hot-topics Welcome to Mayo Medical Laboratories Hot Topics. These presentations provide short discussion

More information

How To Treat An Alcoholic Withdrawal

How To Treat An Alcoholic Withdrawal Alcohol Withdrawal Sorrento, Italy (September 19, 2007) Lewis R. Goldfrank, MD Professor and Chairman, Emergency Medicine New York University School of Medicine Director, Emergency Medicine Bellevue Hospital/NYU

More information

EPIDEMIC 4.6 % OF INDIVIDUALS 18 25 USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH.

EPIDEMIC 4.6 % OF INDIVIDUALS 18 25 USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH. Drug Court EPIDEMIC In the 10 years (1997 2007) the per capita retail purchases of Methadone, Hydrocodone and Oxycodone in the United States increased 13-fold, 4-fold and 9-fold, respectively. 4.6 % OF

More information

HIV Case Conference: Use of Common Benzodiazepines

HIV Case Conference: Use of Common Benzodiazepines F/C AETC Faculty Psych Thursday, May 15, 2014 12:30 1:30pm (EDT) Didactic Presenter Patrick Marsh, MD University of South Florida Facilitator Debbie Cestaro Seifer, MS, RN University of South Florida HIV

More information

Pelagia Research Library

Pelagia Research Library Available online at www.pelagiaresearchlibrary.com Der Chemica Sinica, 2011, 2 (2): 46-51 Heroin: Assessment of use and abuse: A Review Asheesh Kumar a, Abhishek Pathak a and S. K. Starling a* ISSN: 0976-8505

More information

Treatment of opioid use disorders

Treatment of opioid use disorders Treatment of opioid use disorders Gerardo Gonzalez, MD Associate Professor of Psychiatry Director, Division of Addiction Psychiatry Disclosures I have no financial conflicts to disclose I will review evidence

More information

Acute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC

Acute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC Acute Pain Management in the Opioid Dependent Patient Maripat Welz-Bosna MSN, CRNP-BC Relieving Pain in America (IOM) More then 116 Million Americans have pain the persists for weeks to years $560-635

More information

Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain

Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain Division of Workers Compensation 04.01.2015 Background Opioids

More information

Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling

Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling Patients with a substance misuse history are at increased risk of receiving inadequate

More information

Tramadol Educational Resource Materials

Tramadol Educational Resource Materials Tramadol Educational Resource Materials Audit Materials November 2013 (Updated August 2014) These educational resource materials have been prepared by a multiprofessional collaborative group, with support

More information

Use of Buprenorphine in the Treatment of Opioid Addiction

Use of Buprenorphine in the Treatment of Opioid Addiction Use of Buprenorphine in the Treatment of Opioid Addiction Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Executive Summary Which of the following is an

More information

EPIDEMIOLOGY OF OPIATE USE

EPIDEMIOLOGY OF OPIATE USE Opiate Dependence EPIDEMIOLOGY OF OPIATE USE Difficult to estimate true extent of opiate dependence Based on National Survey of Health and Mental Well Being: 1.2% sample used opiates in last 12 months

More information

Medical Malpractice Treatment Alprazolam benzodiazepine - A Case Study

Medical Malpractice Treatment Alprazolam benzodiazepine - A Case Study Improving Outcomes in Patients Who are Prescribed Alprazolam with Concurrent Use of Opioids Pik-Sai Yung, M.D. Staff Psychiatrist Center for Counseling at Walton Background and Rationale Alprazolam is

More information

Downers/Depressants (pages 40-50)

Downers/Depressants (pages 40-50) Downers/Depressants (pages 40-50) Read pages 49-54, 59-60, and 78-79 of the booklet, Street Drugs. Pages 40-50 of the text. Narcotics: Prescription Origin: Southeast Asia, Southwest Asia, and in the Western

More information

DEVELOPING MANUFACTURING SUPPLYING. Naltrexone Implants. Manufactured by NalPharm Ltd WWW.NALPHARM.COM

DEVELOPING MANUFACTURING SUPPLYING. Naltrexone Implants. Manufactured by NalPharm Ltd WWW.NALPHARM.COM DEVELOPING MANUFACTURING SUPPLYING Naltrexone Implants Background to Nalpharm NalPharm is a specialist pharmaceutical company supplying proprietary branded medications and generic drugs in the area of

More information

Pain Medication Taper Regimen Time frame to taper off 30-60 days

Pain Medication Taper Regimen Time frame to taper off 30-60 days Pain Medication Taper Regimen Time frame to taper off 30-60 days Medication to taper Taper Regimen Comments Methadone Taper by no more than 25% Morphine Taper by no more than 25% Tramadol Taper by no more

More information

CLINICAL POLICY Department: Medical Management Document Name: Vivitrol Reference Number: NH.PHAR.96 Effective Date: 03/12

CLINICAL POLICY Department: Medical Management Document Name: Vivitrol Reference Number: NH.PHAR.96 Effective Date: 03/12 Page: 1 of 7 IMPORTANT REMINDER This Clinical Policy has been developed by appropriately experienced and licensed health care professionals based on a thorough review and consideration of generally accepted

More information

New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery

New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery USING THE 48 HOUR OBSERVATION BED USING THE 48 HOUR OBSERVATION BED Detoxification

More information

Frequently asked questions

Frequently asked questions Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction Frequently asked questions What is Naltrexone? Naltrexone is a prescription drug that completely blocks the effects of all opioid drugs

More information

TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION

TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION The Tennessee Board of Medical Examiners has reviewed the Model Policy Guidelines for Opioid Addiction Treatment

More information

PHARMACOLOGIC TREATMENT OF COMMON SUBSTANCE ABUSE DISORDERS LAUREN FISKE, MS4

PHARMACOLOGIC TREATMENT OF COMMON SUBSTANCE ABUSE DISORDERS LAUREN FISKE, MS4 PHARMACOLOGIC TREATMENT OF COMMON SUBSTANCE ABUSE DISORDERS LAUREN FISKE, MS4 ACUTE ALCOHOL INTOXICATION Naloxone for patients in coma and/or with respiratory depression (empiric treatment for opioid poisoning)

More information

Opioid Addiction and Methadone: Myths and Misconceptions. Nicole Nakatsu WRHA Practice Development Pharmacist

Opioid Addiction and Methadone: Myths and Misconceptions. Nicole Nakatsu WRHA Practice Development Pharmacist Opioid Addiction and Methadone: Myths and Misconceptions Nicole Nakatsu WRHA Practice Development Pharmacist Learning Objectives By the end of this presentation you should be able to: Understand how opioids

More information

Opioid dependence is a chronic relapsing condition that

Opioid dependence is a chronic relapsing condition that PEER REVIEWED FEATURE Treatment of patients with opioid dependence NICHOLAS LINTZERIS BMedSci, MB BS, PhD, FAChAM The prevalence of opioid dependence is growing in Australia with the increased use of pharmaceutical

More information

UNIT VIII NARCOTIC ANALGESIA

UNIT VIII NARCOTIC ANALGESIA UNIT VIII NARCOTIC ANALGESIA Objective Review the definitions of Analgesic, Narcotic and Antagonistic. List characteristics of Opioid analgesics in terms of mechanism of action, indications for use and

More information

Prior Authorization Guideline

Prior Authorization Guideline Prior Authorization Guideline Guideline: PDP IBT Inj - Vivitrol Therapeutic Class: Central Nervous System Agents Therapeutic Sub-Class: Opiate Antagonist Client: 2007 PDP IBT Inj Approval Date: 2/20/2007

More information

Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur

Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur Drug and Alcohol Dependence 69 (2003) 233/241 www.elsevier.com/locate/drugalcdep Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur Edward C.

More information

Acute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction

Acute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction Acute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction June 9, 2011 Tufts Health Care Institute Program on Opioid Risk Management Daniel

More information

Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction. Frequently Asked Questions

Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction. Frequently Asked Questions Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction Frequently Asked Questions What is Naltrexone? Naltrexone is a prescription drug that effectively blocks the effects of heroin, alcohol,

More information

Adjunctive psychosocial intervention. Conditions requiring dose reduction. Immediate, peak plasma concentration is reached within 1 hour.

Adjunctive psychosocial intervention. Conditions requiring dose reduction. Immediate, peak plasma concentration is reached within 1 hour. Shared Care Guideline for Prescription and monitoring of Naltrexone Hydrochloride in alcohol dependence Author(s)/Originator(s): (please state author name and department) Dr Daly - Consultant Psychiatrist,

More information

Teen Misuse and Abuse of Alcohol and Prescription Drugs. Information for Parents

Teen Misuse and Abuse of Alcohol and Prescription Drugs. Information for Parents Teen Misuse and Abuse of Alcohol and Prescription Drugs Information for Parents Terminology Misuse: Using a drug in a way in which it was not intended Example: Using a higher dose of medication than was

More information

MANAGEMENT OF CHRONIC NON MALIGNANT PAIN

MANAGEMENT OF CHRONIC NON MALIGNANT PAIN MANAGEMENT OF CHRONIC NON MALIGNANT PAIN Introduction The Manitoba Prescribing Practices Program (MPPP) recognizes the important role served by physicians in relieving pain and suffering and acknowledges

More information

PROTOCOL SYNOPSIS Evaluation of long-term opioid efficacy for chronic pain

PROTOCOL SYNOPSIS Evaluation of long-term opioid efficacy for chronic pain P a g e 1 PROTOCOL SYNOPSIS Evaluation of long-term opioid efficacy for chronic pain Clinical Phase 4 Study Centers Study Period 25 U.S. sites identified and reviewed by the Steering Committee and Contract

More information

Alcohol Withdrawal. Introduction. Blood Alcohol Concentration. DSM-IV Criteria/Alcohol Abuse. Pharmacologic Effects of Alcohol

Alcohol Withdrawal. Introduction. Blood Alcohol Concentration. DSM-IV Criteria/Alcohol Abuse. Pharmacologic Effects of Alcohol Pharmacologic Effects of Alcohol Alcohol Withdrawal Kristi Theobald, Pharm.D., BCPS Therapeutics III Fall 2003 Inhibits glutamate receptor function (NMDA receptor) Inhibits excitatory neurotransmission

More information

Developing Medications to Treat Addiction: Implications for Policy and Practice. Nora D. Volkow, M.D. Director National Institute on Drug Abuse

Developing Medications to Treat Addiction: Implications for Policy and Practice. Nora D. Volkow, M.D. Director National Institute on Drug Abuse Developing Medications to Treat Addiction: Implications for Policy and Practice Nora D. Volkow, M.D. Director National Institute on Drug Abuse Medications Currently Available For Nicotine Addiction Nicotine

More information

THE BASICS. Community Based Medically Assisted Alcohol Withdrawal. World Health Organisation 2011. The Issues 5/18/2011. RCGP Conference May 2011

THE BASICS. Community Based Medically Assisted Alcohol Withdrawal. World Health Organisation 2011. The Issues 5/18/2011. RCGP Conference May 2011 RCGP Conference May 2011 Community Based Medically Assisted Alcohol Withdrawal THE BASICS An option for consideration World Health Organisation 2011 Alcohol is the world s third largest risk factor for

More information

UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths

UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths Joanna G Katzman, M.D., M.S.P.H Director, UNM Pain Center Associate Professor,

More information

Section Editor Andrew J Saxon, MD

Section Editor Andrew J Saxon, MD Official reprint from UpToDate www.uptodate.com 2015 UpToDate Pharmacotherapy for opioid use disorder Author Eric Strain, MD Section Editor Andrew J Saxon, MD Deputy Editor Richard Hermann, MD All topics

More information

Update and Review of Medication Assisted Treatments

Update and Review of Medication Assisted Treatments Update and Review of Medication Assisted Treatments for Opiate and Alcohol Use Disorders Richard N. Whitney, MD Medical Director Addiction Services Shepherd Hill Newark, Ohio Medication Assisted Treatment

More information

Low dose naltrexone as a treatment for multiple sclerosis

Low dose naltrexone as a treatment for multiple sclerosis Low dose naltrexone as a treatment for multiple sclerosis Can I take study demonstrated that naltrexone The low dose naltrexone as a treatment for multiple sclerosis should be of naltrexone is microcrystalline

More information

How To Treat Alcohol Withdrawal In The Elderly

How To Treat Alcohol Withdrawal In The Elderly ALCOHOL ABUSE AND WITHDRAWAL SYNDROME IN THE ELDERLY Colin Muscat Family Medicine Case 90 year old Female Lives with son on vacation Admitted for FTT Consult -? GARP Develops increasing confusion during

More information

Describe and discuss tramadol as a novel opioid, including risks and benefits Describe and discuss the problem of

Describe and discuss tramadol as a novel opioid, including risks and benefits Describe and discuss the problem of Addiction Medicine James R. Knight, MD Clinical Assistant Professor of Internal Medicine & Pediatrics Division of Hospital Medicine The Ohio State University Wexner Medical Center Objectives Describe and

More information

Medication-Assisted Treatment (MAT) & What It Means Long-Term Gary K. Byrd., M.Ed., MAC, CCS, CAMS Methadone is the Gold Standard for treatment of chronic heroin addiction Gary Byrd 2015 1 Gary Byrd 2015

More information

INTRODUCTION MATERIALS AND METHODS

INTRODUCTION MATERIALS AND METHODS Characteristic features of patients hospitalized with Narcotic poisoning in Yazd, Iran Vida Ayatollahi 1, Shokoufeh Behdad 1, Hamid Oliwiaie 2, Mohammad Reza Hajiesmaili 1* Maryam Dehghan 1, Omid Mehrpour

More information

Drug Abuse/Overdose. By : Dr. Ragia M Hegazy, M.D. Assistant professor of Clinical Toxicology

Drug Abuse/Overdose. By : Dr. Ragia M Hegazy, M.D. Assistant professor of Clinical Toxicology Drug Abuse/Overdose By : Dr. Ragia M Hegazy, M.D. Assistant professor of Clinical Toxicology OPIATES DESIRED EFFECTS OF USE The Rush Sedation Euphoria Analgesia OPIUM COMES FROM THE POPPY PLANT PAPAVER

More information

Medication-Assisted Addiction Treatment

Medication-Assisted Addiction Treatment Medication-Assisted Addiction Treatment Molly Carney, Ph.D., M.B.A. Executive Director Evergreen Treatment Services Seattle, WA What is MAT? MAT is the use of medications, in combination with counseling

More information

Abstral Prescriber and Pharmacist Guide

Abstral Prescriber and Pharmacist Guide Abstral Prescriber and Pharmacist Guide fentanyl citrate sublingual tablets Introduction The Abstral Prescriber and Pharmacist Guide is designed to support healthcare professionals in the diagnosis of

More information

Drug overdose death rates by state per 100,000 people (2008) SOURCE: National Vital Statistics System, 2008

Drug overdose death rates by state per 100,000 people (2008) SOURCE: National Vital Statistics System, 2008 PRESCRITPION DRUG ABUSE: AN EPIDEMIC What is Addiction? By: Lon R. Hays, M.D., M.B.A. Professor and Chairman Department of Psychiatry University of Kentucky Healthcare Addiction is a primary, chronic disease

More information

Harnessing National Data Sets to Measure Safety of Opioid Treatment: National Survey on Drug Use and Health (NSDUH) and VA Data

Harnessing National Data Sets to Measure Safety of Opioid Treatment: National Survey on Drug Use and Health (NSDUH) and VA Data Harnessing National Data Sets to Measure Safety of Opioid Treatment: National Survey on Drug Use and Health (NSDUH) and VA Data William C. Becker, MD Assistant Professor, General Internal Medicine VA Connecticut

More information

Urine Drug Testing Methadone 101 Methadone for hospitalists

Urine Drug Testing Methadone 101 Methadone for hospitalists Urine Drug Testing Methadone 101 Methadone for hospitalists Dr. Patricia Mark MB, BCh LEARNING OBJECTIVES Clarify the purpose of urine drug testing Distinguish between UDT for detection of illicit drug

More information

Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence

Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence Information for Family Members Family members of patients who have been prescribed buprenorphine/naloxone for treatment of opioid addiction

More information

Neurobiology and Treatment of Opioid Dependence. Nebraska MAT Training September 29, 2011

Neurobiology and Treatment of Opioid Dependence. Nebraska MAT Training September 29, 2011 Neurobiology and Treatment of Opioid Dependence Nebraska MAT Training September 29, 2011 Top 5 primary illegal drugs for persons age 18 29 entering treatment, % 30 25 20 15 10 Heroin or Prescription Opioids

More information

Co-morbid physical disorders e.g. HIV, hepatitis C, diabetes, hypertension. Medical students will gain knowledge in

Co-morbid physical disorders e.g. HIV, hepatitis C, diabetes, hypertension. Medical students will gain knowledge in 1.0 Introduction Medications are used in the treatment of drug, alcohol and nicotine dependence to manage withdrawal during detoxification, stabilisation and substitution as well as for relapse prevention,

More information

Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone )

Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone ) Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone ) Elinore F. McCance-Katz, M.D., Ph.D. Professor and Chair, Addiction Psychiatry Virginia Commonwealth University Neurobiology of Opiate

More information

MEDICATIONS USED IN THE MANAGEMENT OF SUBSTANCE USE DISORDERS

MEDICATIONS USED IN THE MANAGEMENT OF SUBSTANCE USE DISORDERS MEDIATIONS USED IN THE MANAGEMENT OF SUBSTANE USE DISORDERS Opioid Agonist Therapy (OAT) for Opioid Dependence Methadone (Dolophine, Methadose) Specialty consultation advised. Titrate carefully, consider

More information

Jennifer Sharpe Potter, PhD, MPH Associate Professor Division of Alcohol and Drug Addiction Department of Psychiatry

Jennifer Sharpe Potter, PhD, MPH Associate Professor Division of Alcohol and Drug Addiction Department of Psychiatry Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin, and Combined Users: Findings From Starting Treatment With Agonist Replacement Therapies (START) Jennifer

More information

Drug Treatment Considerations In The Elderly

Drug Treatment Considerations In The Elderly Drug Treatment Considerations In The Elderly by Gordon Mallarkey Download Drug Treatment Considerations In The Elderly online in pdf Here you can see related and other interesting book : Pharmacotherapy

More information

Understanding Addiction: The Intersection of Biology and Psychology

Understanding Addiction: The Intersection of Biology and Psychology Understanding Addiction: The Intersection of Biology and Psychology Robert Heimer, Ph.D. Yale University School of Public Health Center for Interdisciplinary Research on AIDS New Haven, CT, USA November

More information

OVERVIEW OF MEDICATION ASSISTED TREATMENT

OVERVIEW OF MEDICATION ASSISTED TREATMENT Sarah Akerman MD Assistant Professor of Psychiatry Director of Addiction Services Geisel School of Medicine/Dartmouth-Hitchcock Medical Center OVERVIEW OF MEDICATION ASSISTED TREATMENT Conflicts of Interest

More information

2.6.4 Medication for withdrawal syndrome

2.6.4 Medication for withdrawal syndrome .6.3 Self-medication Self-medication presents a risk during alcohol withdrawal, particularly when there is minimal supervision (low level and medium level 1 settings). Inform patients of the risk of selfmedication

More information

Drug- and Alcohol-Related Intoxication Deaths in Maryland, 2014

Drug- and Alcohol-Related Intoxication Deaths in Maryland, 2014 Maryland Department of Health and Mental Hygiene Larry Hogan, Governor Boyd Rutherford, Lt. Governor Van Mitchell, Secretary May, 215 Drug- and Alcohol-Related Intoxication Deaths in Maryland, 214 Table

More information

The University of Toledo - Main Campus Policy

The University of Toledo - Main Campus Policy The University of Toledo - Main Campus Policy IV-12 3360-30-12 Alcohol and Substance Abuse. (A) Alcohol and drug abuse policy statement The University of Toledo is committed to promoting and maintaining

More information

GUIDELINES FOR COMMUNITY ALCOHOL DETOXIFICATION IN SHARED CARE

GUIDELINES FOR COMMUNITY ALCOHOL DETOXIFICATION IN SHARED CARE GUIDELINES FOR COMMUNITY ALCOHOL DETOXIFICATION IN SHARED CARE Dr Millicent Chikoore MBBS MRCPsych Dr O Lagundoye MBBS MRCPsych Community based alcohol detoxification is a safe and effective option for

More information

Opioid Dependence and Buprenorphine: An Update

Opioid Dependence and Buprenorphine: An Update Opioid Dependence and Buprenorphine: An Update Elinore F. McCance-Katz MD, PhD Medical Director Physicians Clinical Support System Buprenorphine Professor of Psychiatry University of California San Francisco

More information

opiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 Ranked #1 123 Drug Rehab Centers in New Jersey 100 Top 10 380

opiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 Ranked #1 123 Drug Rehab Centers in New Jersey 100 Top 10 380 opiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 ed #1 123 Drug Rehab Centers in New Jersey 100 Top 10 380 effects of alcohol in the brain 100 Top 30 698 heroin addiction 100

More information

Psychotherapeutic Medications: What Every Counselor Should Know

Psychotherapeutic Medications: What Every Counselor Should Know Psychotherapeutic Medications: What Every Counselor Should Know Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Antipsychotics/Neuroleptics Antipsychotics,

More information

MEDICAL ASSISTANCE BULLETIN

MEDICAL ASSISTANCE BULLETIN ISSUE DATE SUBJECT EFFECTIVE DATE MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Opiate Dependence Treatments Pharmacy Service Leesa M. Allen, Deputy Secretary Office of Medical

More information

Drug Utilization Is On The Rise

Drug Utilization Is On The Rise Objectives Identify the clinical issues related to opioid prescribing for chronic pain indications Define the clinical needs and expectations of urine drug testing in pain management Address preanalytical

More information

CONTROLLED SUBSTANCE CONTRACT

CONTROLLED SUBSTANCE CONTRACT CONTROLLED SUBSTANCE CONTRACT The purpose of this contract is to protect my access to controlled substances and to protect our ability to prescribe for you. The long-term use of substances such as opiates

More information

Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians

Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians Although prescription pain medications are intended to improve the lives of people with pain, their increased use and misuse

More information

Prescription Drugs: Abuse and Addiction

Prescription Drugs: Abuse and Addiction EAP Drug Free Workplace Newsletter March 2014 Prescription Drugs: Abuse and Addiction What are some of the commonly abused prescription drugs? Although many prescription drugs can be abused or misused,

More information

Heroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health?

Heroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health? Heroin Heroin is an opiate drug that is synthesized from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears as a white or brown

More information

One example: Chapman and Huygens, 1988, British Journal of Addiction

One example: Chapman and Huygens, 1988, British Journal of Addiction This is a fact in the treatment of alcohol and drug abuse: Patients who do well in treatment do well in any treatment and patients who do badly in treatment do badly in any treatment. One example: Chapman

More information

Prescribing and Tapering Benzodiazepines

Prescribing and Tapering Benzodiazepines E-Resource October, 2014 Prescribing and Tapering Benzodiazepines The use of benzodiazepines has grown over time and evidence has shown that long term use of these drugs has very little benefit with many

More information

Appropriate Use of UDT to Improve Patient Care

Appropriate Use of UDT to Improve Patient Care Published on OpioidRisk (http://www.opioidrisk.com) Home > Urine Drug Testing Urine Drug Testing This guide provides: Download Entire Guide [1] Appropriate use of Urine Drug Testing (UDT) to improve patient

More information

BENZODIAZEPINE CONSIDERATIONS IN WORKERS COMPENSATION: IMPLICATIONS FOR WORK DISABILITY AND CLAIM COSTS By: Michael Erdil MD, FACOEM

BENZODIAZEPINE CONSIDERATIONS IN WORKERS COMPENSATION: IMPLICATIONS FOR WORK DISABILITY AND CLAIM COSTS By: Michael Erdil MD, FACOEM 3 rd Quarter 2015 BENZODIAZEPINE CONSIDERATIONS IN WORKERS COMPENSATION: IMPLICATIONS FOR WORK DISABILITY AND CLAIM COSTS By: Michael Erdil MD, FACOEM Introduction Benzodiazepines, sometimes called "benzos",

More information

Update on Buprenorphine: Induction and Ongoing Care

Update on Buprenorphine: Induction and Ongoing Care Update on Buprenorphine: Induction and Ongoing Care Elizabeth F. Howell, M.D., DFAPA, FASAM Department of Psychiatry, University of Utah School of Medicine North Carolina Addiction Medicine Conference

More information

MOH CLINICAL PRACTICE GUIDELINES 2/2008 Prescribing of Benzodiazepines

MOH CLINICAL PRACTICE GUIDELINES 2/2008 Prescribing of Benzodiazepines MOH CLINICL PRCTICE GUIELINES 2/2008 Prescribing of Benzodiazepines College of Family Physicians, Singapore cademy of Medicine, Singapore Executive summary of recommendations etails of recommendations

More information

Patients are still addicted Buprenorphine is simply a substitute for heroin or

Patients are still addicted Buprenorphine is simply a substitute for heroin or BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals Module VI: Myths About the Use of Medication in Recovery Patients are still addicted Buprenorphine is simply a substitute

More information

Alcohol and Drug. A Cochrane Handbook. losief Abraha MD. Cristina Cusi MD. Regional Health Perugia

Alcohol and Drug. A Cochrane Handbook. losief Abraha MD. Cristina Cusi MD. Regional Health Perugia Alcohol and Drug A Cochrane Handbook losief Abraha MD Regional Health Perugia of Cristina Cusi MD Outpatient Services - Neurology Clinical Institutes of Specialisation Milan Italy A John Sons, Ltd., THE

More information

young adults were at increased risk of nonmedical opioid use, which increases the risk of future substance use disorders. 5

young adults were at increased risk of nonmedical opioid use, which increases the risk of future substance use disorders. 5 TITLE: Suboxone Versus Methadone for the Detoxification of Patients Addicted to Prescription Opioids: A Review of Comparative Clinical Effectiveness, Safety, and Guidelines DATE: 13 February 2014 CONTEXT

More information